- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07425769
Tilpasning av RDAD for DS (CareFit DS/AD)
Tilpasning av RDAD-intervensjonen for personer med Downs syndrom Fase 3 - Pilot test
The goal of this clinical trial is to observe feasibility and initial efficacy of a remotely delivered exercise and dementia caregiving intervention in older adults with Down syndrome and their caregivers.
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
In Adapting RDAD for DS Phase 3 (CareFit-DS/AD), we will conduct a 12-week, single arm pilot trial intervention in 20 adults with DS/caregiver dyads. This intervention includes remote-delivered functional exercise classes for adults with DS and their caregivers, and remote delivered dementia caregiving training sessions for the caregivers. Participants with DS will complete 12 weeks of group exercise sessions (three ~30-minute sessions per week, caregiver optional) over video call, and caregivers will also receive a weekly ~40-minute group video call session of a dementia caregiver training/support group.
For participants within 50 miles of the study site, staff will travel to participant homes at baseline and following 12 weeks to perform assessments of physical function and to set up the Actigraph accelerometers. Saliva collection kits for caregivers will be mailed ahead of time and picked up at the home visit. Additionally, at baseline staff will deliver equipment for intervention delivery
For participants greater than 50 miles of the study site, staff will mail study equipment, including the Actigraph accelerometer, and schedule a video orientation meeting to assist with equipment setup. Physical function and caregiver saliva collection will not be collected for these participants.
Twelve unique pre-recorded exercise class sessions (endurance, strength, balance, and flexibility) will be performed 3 times each throughout the study (36 sessions total). The exercise session content and frequency are designed to improve functional fitness for daily activities and will challenge participants at a light and/or moderate intensity level. During the sessions, all participants will join a video call and follow along with a pre-recorded exercise video in a group format. A staff member trained in working with the population will be on the call to provide encouragement and feedback, while monitoring for participant safety. Caregivers may attend and participate in the exercise sessions, but will neither be encouraged or discouraged from doing so.
Caregivers will be asked to attend weekly group behavioral management training sessions via video call immediately following one of the 3 exercise sessions. These meetings will consist of information and resources for caregiving for a person with DS who has been diagnosed with dementia. The group will be moderated by a staff member trained in working with the population and will include presented information as well as group discussion time. Topics include the Overview of Alzheimer's Disease in Down Syndrome; Behavior Management Strategies, Changing Expectations, etc.
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Kansas
-
Kansas City, Kansas, Forente stater, 66160
- University of Kansas Medical Center
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
- Voksen
- Eldre voksen
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria - Adults with Down syndrome:
- Age >35 yrs. with a diagnosis of DS as self-reported or reported by caregiver. This age range was selected as cognitive decline related to AD is observed at age ~31 in adults with DS.
- Sufficient functional ability to understand directions, communicate preferences, wants, and needs through spoken language.
- Living at home or in a supported living environment with a parent/caregiver who agrees to serve as a study partner.
- Self-reported ability to participate in physical activity.
Exclusion Criteria - Adults with Down syndrome:
- Unable to participate in moderate-to-vigorous physical activity.
- Self-reported, cardiovascular, metabolic or renal disease and/or signs or symptoms.
Inclusion Criteria - Caregivers
- Age ≥18 yrs.
- Reports being a primary caregiver of an adult with DS.
- English speaking.
- Self-reported ability to participate in physical activity.
Exclusion Criteria - Caregivers
- Unable to participate in moderate PA, i.e., brisk walking.
- Self-reported, cardiovascular, metabolic or renal disease and/or signs or symptoms.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Remote Exercise and Caregiver Education
Single Arm with active intervention for remote exercise and caregiver education sessions |
Participants will take part in thrice weekly exercise sessions using pre-recorded videos designed for older adults with Down syndrome. Participants will join video call and follow along with the video. A staff member familiar with the population will be on the call to provide modifications, encouragement and ensure participant safety. Caregivers will join a once-weekly education session held via video call and led by a trained staff member. Education content will include how to support and manage challenging behaviors of older adults with Down syndrome who may be experiencing Alzheimer's disease-related symptoms. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Feasibility: Participant Recruitment
Tidsramme: Baseline
|
Number of participants enrolled divided by number eligible on questionnaire |
Baseline
|
|
Feasibility: Recruitment Rate
Tidsramme: Baseline
|
Number of participants enrolled per month of active recruitment |
Baseline
|
|
Feasibility: Participant retention
Tidsramme: Baseline to Week 12
|
Calculated as number of participants completing the intervention divided by the number who initiate the intervention multiplied by 100 |
Baseline to Week 12
|
|
Feasibility: Session Attendance
Tidsramme: Across 12 week intervention
|
Calculated as the percentage of sessions attended across 12 weeks. |
Across 12 week intervention
|
|
Feasibility: Participant Safety
Tidsramme: Across 12 week intervention
|
Will be expressed as the total number of self-reported adverse events. |
Across 12 week intervention
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Participant Sedentary Time
Tidsramme: Baseline and Week 12
|
Assessed using an ActiGraph wGT3x-BT accelerometer (ActiGraph LLC, Pensacola, FL) worn on the non-dominant wrist over 7 consecutive days. |
Baseline and Week 12
|
|
Participant Physical Activity
Tidsramme: Baseline and Week 12
|
Light, moderate and vigorous physical activity will be assessed using an ActiGraph wGT3x-BT accelerometer (ActiGraph LLC, Pensacola, FL) worn on the non-dominant wrist over 7 consecutive days. |
Baseline and Week 12
|
|
Participant Five Times Sit to Stand
Tidsramme: Baseline and Week 12
|
Time required to stand up and return to seated position 5 times. Lower time indicates increased physical function. This will be collected from participants living within 50 miles of the study site during a home visit. |
Baseline and Week 12
|
|
Participant Timed Up and Go
Tidsramme: Baseline and Week 12
|
Time required to stand from a chair, walk 3 meters, pivot around a cone and return to a seated position. Lower times indicate increased physical function. This will be collected from participants living within 50 miles of the study site during a home visit. |
Baseline and Week 12
|
|
Participant 2 Minute Step Test
Tidsramme: Baseline and Week 12
|
Number of steps with knees reaching a height of the midpoint of the femur participants are able to complete in 2 minutes. Higher scores indicate increased physical function. This will be collected from participants living within 50 miles of the study site during a home visit. |
Baseline and Week 12
|
|
Participant Frailty and Injuries: Cooperative Studies of Intervention Techniques (FICSIT-4)
Tidsramme: Baseline and Week 12
|
The FICSIT-4 assesses static balance by positioning participants in 4 different stances: feet side-by-side; feet semi-tandem; feet tandem; and one foot. Each stance is attempted to be held for 10 seconds. Higher scores indicate improved physical function. This will be collected from participants living within 50 miles of the study site during a home visit. |
Baseline and Week 12
|
|
Participant Hand Grip Strength
Tidsramme: Baseline and Week 12
|
Grip strength for both the dominant and non-dominant hands will be assessed in triplicate and then scores averaged. Higher number indicate increased physical function. This will be collected from participants living within 50 miles of the study site during a home visit. |
Baseline and Week 12
|
|
Participant Basic and Instrumental Activities of Daily Living
Tidsramme: Baseline and Week 12
|
Will be assessed by proxy (caregiver report) using the 17-item Waisman Activities of Daily Living survey. Higher scores indicate increased independence with ADLs. |
Baseline and Week 12
|
|
Participant Behavioral Symptom-Related Severity
Tidsramme: Baseline and Week 12
|
Will be assessed by proxy report with the Neuropsychiatric Inventory Questionnaire (NPI-Q). Higher scores indicate increased frequency and severity of behavioral symptoms. |
Baseline and Week 12
|
|
Participant Physical Function: PROMIS Short Form V2.0 Physical Function Surveys 8b and 8c
Tidsramme: Baseline and week 12
|
Participant physical function will be assessed by self-report using PROMIS Short Form Surveys 8b and 8c. These surveys consist of questions pertaining to ability to perform activities of daily living. Responses are on a 5 point scale ranging from 'Without any difficulty' scoring 5, to 'Unable to do' scoring 1. Higher scores indicate improved physical function. |
Baseline and week 12
|
|
Caregiver Sedentary Time
Tidsramme: Baseline and Week 12
|
Assessed using an ActiGraph wGT3x-BT accelerometer (ActiGraph LLC, Pensacola, FL) worn on the non-dominant wrist over 7 consecutive days. |
Baseline and Week 12
|
|
Caregiver Physical Activity
Tidsramme: Baseline and Week 12
|
Light, moderate and vigorous physical activity will be assessed using an ActiGraph wGT3x-BT accelerometer (ActiGraph LLC, Pensacola, FL) worn on the non-dominant wrist over 7 consecutive days. |
Baseline and Week 12
|
|
Caregiver Five Times Sit to Stand
Tidsramme: Baseline and Week 12
|
Time required to stand up and return to seated position 5 times. Lower time indicates increased physical function. This will be collected from participants living within 50 miles of the study site during a home visit. |
Baseline and Week 12
|
|
Caregiver Timed Up and Go
Tidsramme: Baseline and Week 12
|
Time required to stand from a chair, walk 3 meters, pivot around a cone and return to a seated position. Lower times indicate increased physical function. This will be collected from participants living within 50 miles of the study site during a home visit. |
Baseline and Week 12
|
|
Caregiver 2 Minute Step Test
Tidsramme: Baseline and Week 12
|
Number of steps with knees reaching a height of the midpoint of the femur participants are able to complete in 2 minutes. Higher scores indicate increased physical function. This will be collected from participants living within 50 miles of the study site during a home visit. |
Baseline and Week 12
|
|
Caregiver Frailty and Injuries: Cooperative Studies of Intervention Techniques (FICSIT-4)
Tidsramme: Baseline and Week 12
|
The FICSIT-4 assesses static balance by positioning participants in 4 different stances: feet side-by-side; feet semi-tandem; feet tandem; and one foot. Each stance is attempted to be held for 10 seconds. Higher scores indicate improved physical function. This will be collected from participants living within 50 miles of the study site during a home visit. |
Baseline and Week 12
|
|
Caregiver Hand Grip Strength
Tidsramme: Baseline and Week 12
|
Grip strength for both the dominant and non-dominant hands will be assessed in triplicate and then scores averaged. Higher number indicate increased physical function. This will be collected from participants living within 50 miles of the study site during a home visit. |
Baseline and Week 12
|
|
Caregiver Strain
Tidsramme: Baseline and Week 12
|
Will be assessed using the Modified Caregiver Strain Index which captures multiple domains of caregiver strain (physical, emotional, financial). Higher scores indicate greater burden and need for support or intervention. |
Baseline and Week 12
|
|
Caregiver Unmet Needs
Tidsramme: Baseline and Week 12
|
Will be assessed by the Measure of Unmet Needs survey. Higher scores indicate larger amounts of unmet caregiver needs. |
Baseline and Week 12
|
|
Caregiver Self Efficacy
Tidsramme: Baseline and Week 12
|
Will be measured using a 9-item dementia caregiver self-efficacy measure. Caregivers will rate their certainty of handling challenging behaviors and access to community services. Higher scores indicate higher self-efficacy. |
Baseline and Week 12
|
|
Caregiver Social Support
Tidsramme: Baseline and Week 12
|
Will be assessed with the Multidimensional Scale of Perceived Social Support (MSPSS). The MSPSS is a 12-item measure of perceived social support measured on a total sum scale and on 3 domains: family, friends, and significant others. Higher scores indicate increased perception of social support. |
Baseline and Week 12
|
|
Caregiver Depression
Tidsramme: Baseline and Week 12
|
Will be measured with the Center for Epidemiologic Studies Depression Scale. Higher scores indicate increased caregiver depression risk. |
Baseline and Week 12
|
|
Caregiver Anxiety
Tidsramme: Baseline and Week 12
|
Will be measured with the Generalized Anxiety Disorder 7-item scale (GAD-7). Higher scores indicate increased anxiety symptoms. |
Baseline and Week 12
|
|
Caregiver Behavioral symptom-related distress
Tidsramme: Baseline and Week 12
|
Will be assessed by a subscale of NPI-Q. higher scores indicate increase symptom-related caregiver distress. |
Baseline and Week 12
|
|
Caregiver Physical Function: PROMIS Short Form V2.0 Physical Function Surveys 8b and 8c
Tidsramme: Baseline and week 12
|
Caregiver physical function will be assessed by self-report using PROMIS Short Form Surveys 8b and 8c. These surveys consist of questions pertaining to ability to perform activities of daily living. Responses are on a 5 point scale ranging from 'Without any difficulty' scoring 5, to 'Unable to do' scoring 1. Higher scores indicate improved physical function. |
Baseline and week 12
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Physiological Stress
Tidsramme: Baseline and Week 12
|
Will be measured by collection and analysis of salivary cortisol. Higher levels of salivary cortisol are correlated with increased stress. This will be collected from participants living within 50 miles of the study site during a home visit. |
Baseline and Week 12
|
|
Intervention Acceptability
Tidsramme: Week 12
|
Will be assessed from audio recorded semi-structured interviews conducted with adult with DS/caregiver dyads within 2 weeks following completion of the 12 week intervention |
Week 12
|
Samarbeidspartnere og etterforskere
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Amy Bodde, PhD, University of Kansas Medical Center
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
- Nevrologiske manifestasjoner
- Hjernesykdommer
- Sykdommer i sentralnervesystemet
- Sykdommer i nervesystemet
- Psykiske lidelser
- Genetiske sykdommer, medfødte
- Nevroatferdsmanifestasjoner
- Nevrokognitive lidelser
- Demens
- Tauopatier
- Nevrodegenerative sykdommer
- Medfødte abnormiteter
- Abnormiteter, flere
- Intellektuell funksjonshemming
- Kromosomforstyrrelser
- Medfødte, arvelige og neonatale sykdommer og abnormiteter
- Alzheimers sykdom
- Downs syndrom
Andre studie-ID-numre
- STUDY00162196
- KL2TR002367 (U.S. NIH-stipend/kontrakt)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .